We are an interdisciplinary research group integrating clinical, molecular and computational neuroscientists, with the common goal of deciphering and treating Parkinson’s disease.  Specifically, our mission is to elucidate mechanisms driving the initiation and progression of PD, to develop biomarkers enabling an early and more precise diagnosis of PD, as well as the stratification of patients according to molecular pathophysiology and to find and test novel neuroprotective therapies able to prevent, slow down or arrest the progression of PD.